Literature DB >> 21134015

Opioid dependence latent structure: two classes with differing severity?

Fiona L Shand1, Tim Slade, Louisa Degenhardt, Andrew Baillie, Elliot C Nelson.   

Abstract

AIMS: To examine the structure of illicit opioid abuse and dependence within an opioid dependent sample and its relationship to other clinical variables. DESIGN, SETTING AND PARTICIPANTS: A cross-sectional study of 1511 opioid dependent individuals recruited through opioid pharmacotherapy clinics in the Sydney area, Australia. MEASUREMENTS: A face-to-face structured interview covering substance use and dependence, psychiatric history, child maltreatment, family background, adult violence and criminal history. Dimensional, latent class and factor mixture models were fit to the opioid abuse and dependence data. Classes were then compared on a range of demographic and clinical covariates.
FINDINGS: A two-class, one-factor model provided the best fit of all the models tested. The two classes differed with respect to endorsement probabilities on a range of abuse and dependence criteria, and also with respect to the odds of other drug dependence diagnoses, antisocial personality disorder and non-fatal opioid overdose. Within-class severity was associated with similar variables: other drug dependence, borderline personality disorder and opioid overdose.
CONCLUSION: In an in-treatment, opioid-dependent sample, there appears to be two classes of individuals exhibiting distinct patterns of abuse and dependence criteria endorsement and to differ on externalizing but not internalizing disorders. This study provides preliminary evidence that the proposed DSM-V opioid use disorder distinction between moderate and severely dependent people is valid. Class one participants were not only more severely dependent, but had greater odds for opioid overdoses, other drug dependence and antisocial personality disorder.
© 2010 The Authors, Addiction © 2010 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2010        PMID: 21134015      PMCID: PMC3465731          DOI: 10.1111/j.1360-0443.2010.03217.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  49 in total

1.  The structure of cannabis dependence in the community.

Authors:  Maree Teesson; Michael Lynskey; Barry Manor; Andrew Baillie
Journal:  Drug Alcohol Depend       Date:  2002-12-01       Impact factor: 4.492

2.  An application of item response theory analysis to alcohol, cannabis, and cocaine criteria in DSM-IV.

Authors:  James W Langenbucher; Erich Labouvie; Christopher S Martin; Pilar M Sanjuan; Lawrence Bavly; Levent Kirisci; Tammy Chung
Journal:  J Abnorm Psychol       Date:  2004-02

3.  A validity study of the SSAGA--a comparison with the SCAN.

Authors:  M Hesselbrock; C Easton; K K Bucholz; M Schuckit; V Hesselbrock
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

4.  The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders.

Authors:  A W Loranger; N Sartorius; A Andreoli; P Berger; P Buchheim; S M Channabasavanna; B Coid; A Dahl; R F Diekstra; B Ferguson
Journal:  Arch Gen Psychiatry       Date:  1994-03

Review 5.  The Christchurch Child Development Study: a review of epidemiological findings.

Authors:  D M Fergusson; L J Horwood; F T Shannon; J M Lawton
Journal:  Paediatr Perinat Epidemiol       Date:  1989-07       Impact factor: 3.980

6.  Brief screening for family psychiatric history: the family history screen.

Authors:  M M Weissman; P Wickramaratne; P Adams; S Wolk; H Verdeli; M Olfson
Journal:  Arch Gen Psychiatry       Date:  2000-07

7.  Cognitive impairment among methadone maintenance patients.

Authors:  S Darke; J Sims; S McDonald; W Wickes
Journal:  Addiction       Date:  2000-05       Impact factor: 6.526

8.  The structure and stability of common mental disorders: the NEMESIS study.

Authors:  W A Vollebergh; J Iedema; R V Bijl; R de Graaf; F Smit; J Ormel
Journal:  Arch Gen Psychiatry       Date:  2001-06

9.  Using latent trait modeling to conceptualize an alcohol problems continuum.

Authors:  Robert F Krueger; Penny E Nichol; Brian M Hicks; Kristian E Markon; Christopher J Patrick; William G Iacono; Matt McGue
Journal:  Psychol Assess       Date:  2004-06

10.  Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients.

Authors:  Caleb J Banta-Green; Joseph O Merrill; Suzanne R Doyle; Denise M Boudreau; Donald A Calsyn
Journal:  Drug Alcohol Depend       Date:  2009-05-26       Impact factor: 4.492

View more
  10 in total

1.  Family-based association analysis of alcohol dependence criteria and severity.

Authors:  Leah Wetherill; Manav Kapoor; Arpana Agrawal; Kathleen Bucholz; Daniel Koller; Sarah E Bertelsen; Nhung Le; Jen-Chyong Wang; Laura Almasy; Victor Hesselbrock; John Kramer; John I Nurnberger; Marc Schuckit; Jay A Tischfield; Xiaoling Xuei; Bernice Porjesz; Howard J Edenberg; Alison M Goate; Tatiana Foroud
Journal:  Alcohol Clin Exp Res       Date:  2013-09-09       Impact factor: 3.455

2.  Utilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers.

Authors:  Patricia Cavazos-Rehg; Richard Grucza; Melissa J Krauss; Austin Smarsh; Nnenna Anako; Erin Kasson; Nina Kaiser; Samantha Sansone; Rachel Winograd; Laura J Bierut
Journal:  Drug Alcohol Depend       Date:  2019-10-28       Impact factor: 4.492

3.  Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients.

Authors:  Deborah S Hasin; Miriam C Fenton; Cheryl Beseler; Jung Yeon Park; Melanie M Wall
Journal:  Drug Alcohol Depend       Date:  2011-10-02       Impact factor: 4.492

4.  Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.

Authors:  Silvia S Martins; Luis E Segura; Julian Santaella-Tenorio; Alexander Perlmutter; Miriam C Fenton; Magdalena Cerdá; Katherine M Keyes; Lilian A Ghandour; Carla L Storr; Deborah S Hasin
Journal:  Addict Behav       Date:  2016-08-30       Impact factor: 3.913

5.  Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model.

Authors:  Thomas F Northrup; Angela L Stotts; Charles Green; Jennifer S Potter; Elise N Marino; Robrina Walker; Roger D Weiss; Madhukar Trivedi
Journal:  Addict Behav       Date:  2014-09-28       Impact factor: 3.913

6.  ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure.

Authors:  Elliot C Nelson; Michael T Lynskey; Andrew C Heath; Naomi Wray; Arpana Agrawal; Fiona L Shand; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Andrew J Schrage; Nancy L Saccone; Pamela A F Madden; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

Review 7.  Pathways through opiate use and offending: A systematic review.

Authors:  Karen P Hayhurst; Matthias Pierce; Matthew Hickman; Toby Seddon; Graham Dunn; John Keane; Tim Millar
Journal:  Int J Drug Policy       Date:  2016-10-19

8.  The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Psychiatry       Date:  2018-11-01       Impact factor: 27.083

9.  Problematic Opioid Use: A Scoping Literature Review of Profiles.

Authors:  Léonie Archambault; Karine Bertrand; Michel Perreault
Journal:  Subst Abuse       Date:  2022-07-28

10.  Early Childhood Behavioral and Academic Antecedents of Lifetime Opioid Misuse among Urban Youth.

Authors:  Jill A Rabinowitz; Beth A Reboussin; Johannes Thrul; Deborah A G Drabick; Geoffrey Kahn; Kerry M Green; Nicholas S Ialongo; Andrew S Huhn; Brion S Maher
Journal:  J Clin Child Adolesc Psychol       Date:  2021-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.